SCHEMBL19216892

SCHEMBL19216892

CCOC(=O)[C@H](CSSC[C@H](NC(C)=O)C(=O)OC)NC(C)=O

nearest known ligand 0.43

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ITGB1 P05556 1/20 0.43
ITGA4 P13612 1/20 0.43
CYP1A2 P05177 1/20 0.41
CYP2C9 P11712 1/20 0.41
CYP2C19 P33261 1/20 0.41
HTT P42858 1/20 0.41
CAD P27708 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
SMN1; SMN2 Q16637 2/20 0.39
KMT2A Q03164 2/20 0.37
POLB P06746 1/20 0.37
ALDH1A1 P00352 2/20 0.35
KDM4E B2RXH2 1/20 0.35
MAPT P10636 1/20 0.35
THRB P10828 1/20 0.35
ALOX15 P16050 1/20 0.35
NFKB1 P19838 1/20 0.35
PTGS2 P35354 1/20 0.35
THPO P40225 1/20 0.35
RECQL P46063 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2953811 0.95 CYP1A2 (0.44) ITGB1ITGA4CYP1A2CYP2C9CYP2C19
SCHEMBL2953812 0.95 CYP1A2 (0.44) ITGB1ITGA4CYP1A2CYP2C9CYP2C19
SCHEMBL2953807 0.95 CYP1A2 (0.44) ITGB1ITGA4CYP1A2CYP2C9CYP2C19
SCHEMBL2408947 0.91 ITGB1 (0.48) ITGB1ITGA4SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2873174 0.91 ITGB1 (0.48) ITGB1ITGA4SMN1; SMN2ALDH1A1KDM4E
SCHEMBL2872923 0.91 ITGB1 (0.48) ITGB1ITGA4SMN1; SMN2ALDH1A1KDM4E
SCHEMBL11773446 0.88 SMN1; SMN2 (0.46) ITGB1ITGA4CYP1A2CYP2C9CYP2C19
SCHEMBL11773441 0.88 SMN1; SMN2 (0.46) ITGB1ITGA4CYP1A2CYP2C9CYP2C19
SCHEMBL24378377 0.87 CYP1A2 (0.40) CYP1A2CYP2C9CYP2C19HTTCAD
SCHEMBL24378315 0.86 ITGB1 (0.44) ITGB1ITGA4SMN1; SMN2ALDH1A1KDM4E

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20170226133-A1 Gold (I)-Phosphine Compounds as Anti-Bacterial Agents AUSPHERIX LIMITED (GB) 2017-08-10 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20170226133-A1 Gold (I)-Phosphine Compounds as Anti-Bacterial Agents RO60, ROCK1, RCN1 ITGB1 3022/4885ITGA4 4078/4885CYP1A2 1595/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.